Foxp3 + regulatory T (T R ) cells are phenotypically and functionally diverse, and broadly distributed in lymphoid and non-lymphoid tissues. However, the molecular pathways guiding the differentiation of tissue-resident T R populations have not been well defined. -eT R are highly enriched in non-lymphoid organs, but virtually absent from blood and lymph. Thus, we propose that tissue-resident T R develop in a multi-step process associated with Id3 downregulation.
Introduction
Several recent studies have highlighted the phenotypic and functional heterogeneity of regulatory T (T R ) cells during both steady state and inflammation (1) (2) (3) (4) . We and others have shown that at steady state in lymphoid organs T R can be broadly divided by expression of CD44 and CD62L into distinct subsets which differ in their localization, dependence on IL-2, and extent of PI3K signaling (2, 5, 6) . Moreover, CD44
hi CD62L lo effector (e)T R display diverse expression of transcription factors and chemokine receptors that promote their migration to inflamed tissues and their response to different types of inflammatory signals (1, 7) . Accordingly, T R found in nonlymphoid tissues have a distinct molecular profile that includes high expression of Gata3 and ST2 ( the IL-33R) and are functionally equipped to suppress inflammation at barrier sites (8) (9) (10) . Although these data highlight the anatomical, functional and molecular diversity of T R , the pathways by which these T R populations differentiate have not been completely defined.
The inhibitors of DNA binding (Id) proteins have been extensively studied in lymphocyte development (11, 12) . Studies of CD8 + effector T cells revealed that Id2 and Id3 are powerful transcriptional regulators of differentiation that are dynamically regulated during T cell activation and effector/memory T cell differentiation (13, 14) . Through their regulation of E protein function, Id2 and Id3 help to control expression of genes essential for CD8 + effector cell differentiation and survival such as Tcf7, Tbx21, Bcl2 and Klrg1 (15) (16) (17) . Although less well studied, Id proteins have been shown to have essential roles in CD4 + T cell function. For instance, Id2 and Id3 are essential for T R maintenance and function, with T R lacking both Id2 and Id3 having impaired proliferation and survival (18) . In T R , Id3 helps to stabilize Foxp3 through restriction of the E protein E47 and its downstream targets Spi-B and SOCS3 (19) . However, Id3 expression is not uniform in T R , and distinct populations of Id3 + and Id3 -have been identified (18, 20) . In this study, we show that Id3 is dynamically regulated in T R , and that progressive loss of Id3 correlates with the stepwise differentiation of highly-functional T R population localized primarily in non-lymphoid tissues.
Results/Discussion
Id3 is dynamically expressed in T R and regulated by TCR signaling
To examine Id3 expression in T R we generated Id3-GFP x Foxp3-mRFP double reporter mice. In agreement with previously published reports, most CD4 + T cells in spleen and lymph nodes (LNs) were Id3 + (18, 20) . However, we noted a subset of Id3 -cells in both Foxp3 + T R and Foxp3 -conventional CD4 + T cell populations ( Fig 1A) . Within T R , the Id3 -population fell exclusively within the CD44 hi CD62L lo eT R compartment (5), whereas Id3 + T R were found in both the CD44 lo CD62L hi central (c)T R and eT R compartments (Fig 1B) . Thus, in secondary lymphoid organs (SLOs) T R can be divided into three distinct subsets based on Id3, CD62L and CD44  expression, Id3  + cT R , Id3  + eT R or Id3  -eT R . Within the Id3  + T R populations Id3  + cT R had higher  Id3 expression than Id3 + eT R measured by GFP-MFI (Fig 1B) , leading us to hypothesize that T R may downregulate Id3 as they transition during their activation and differentiation from cT R into eT R . Indeed, Id3 expression can be downregulated by TCR signaling (18) , and we observed a loss of Id3 expression in the T R compartment correlating with the strength of TCR stimulation when cells were activated with different concentrations of platebound α CD3/28 for 48 hours ( Fig  1C) . To more precisely define the developmental relationship between these T R subsets we sorted Id3 + cT R , Id3 + eT R or Id3 -eT R from spleen and LNs of reporter mice and transferred individual T R populations into RAG1-deficient animals, and evaluated the phenotype and expansion of transferred T R after 2 weeks. Transferred Id3 + cT R gave rise to all three subsets, with some cells retaining Id3 and CD62L expression but the majority converting into Id3 -eT R (Fig 1D) . The bulk of Id3 + eT R downregulated Id3, with no cells regaining CD62L expression, whereas Id3
-eT R did not give rise to either of the other populations, indicating that these cells are likely a terminal differentiated population. Thus, Id3
-eT R appear to develop from Id3 + cT R in a stepwise manner during activation, with Id3 + eT R acting as an intermediate population.
Id3
-eT R express inhibitory markers and are highly suppressive To explore the phenotypic and functional differences between these three subsets of T R , we assessed expression of the T R -associated surface markers on each population of splenic T R .
In agreement with previously published data, cT R and eT R showed distinct phenotypes, with eT R having lower expression of the high affinity IL-2 receptor component CD25, but higher levels of the activation and functional surface markers ICOS, KLRG1, TIGIT, GITR and CTLA4 (Fig 2A) (5, 6) . Moreover, within the eT R compartment the Id3 -T R had higher expression of activation and inhibitory molecules than their Id3 + T R counterparts, and had the lowest expression of CD25. As our lab previously described (5), elevated expression of ICOS and diminished expression of CD25 suggests that Id3 -eT R are less dependent on IL-2 for their homeostatic maintenance, and instead likely rely on continued ICOS signaling. Additionally, increased expression of these T R functional molecules correlated with enhanced in vitro suppressive activity of Id3 -eT R compared with either Id3 + cT R or Id3 + eT R (Fig 2B) .
Transcriptional profiling highlights the stepwise differentiation of Id3 -eT R To identify and compare their unique transcriptional profiles, we performed RNA-seq on sorted Id3 + cT R , Id3 + eT R and Id3 -eT R from spleen or LNs of Id3-GFP x Foxp3-mRFP reporter mice. Although there was little difference between LN and spleen samples, principle component analysis (PCA) showed that each of the three T R populations were transcriptionally distinct ( Fig  3A) , and accordingly we identified 1,672 significantly differentially expressed (DE) genes between the three T R populations (Fig 3B, Supplemental Table 1 ). The largest differences were found between Id3 -eT R and Id3 + cT R with 1,471 DE genes, whereas only 474 genes differed between Id3 + and Id3 -eT R (Fig 3B) . Interestingly among the DE genes we observed a reciprocal increase in Id2 expression as T R lose Id3 (Fig 3C) . This differential Id expression in T R is similar to what occurs in CD8 + T cells, which upregulate Id2 and downregulate Id3 while becoming activated and gaining effector function (13, 14) . This suggests that as T R downregulate Id3, the closely related Id2 may take over some of its functions while also driving a unique E-proteindependent signature promoting eT R development. Consistent with the stepwise differentiation model we propose for these populations, examination of the 300 most DE genes across the three T R subsets (based on highest F-value) showed that both up and downregulated genes were generally expressed in a gradient fashion, with expression in Id3 + eT R falling between that of Id3 + cT R and Id3 -eT R (Fig 3D-E) . Moreover, in accordance with our prior phenotypic analysis and their enhanced suppressive activity, Id3
-eT R showed elevated expression of known T R function genes, including Il10, Ctla4, Pdcd1, Tnfrsf4, Lag3 and Ebi3 (Fig 3F) . Gene Ontology (GO) term enrichment analysis of genes DE between Id3 + eT R and Id3 -eT R identified specific molecular pathways altered between these closely related populations (Fig 3G) . The top six enriched categories all related to cytokine and chemokine receptor signaling, with Id3 -eT R expressing high levels of receptors indicating that they can tune their activity in response to key inflammatory cytokines such as IL-1, IL-18, IL-23, and IL-25 ( Fig 3H) . Moreover, among the DE chemokine receptors, Id3
-eT R had the highest expression of receptors that promote lymphocyte migration to inflamed tissues, such as Ccr1, Ccr2, Ccr4, Ccr10, Cxcr3 and Cxcr6 (Fig 3H) (1) . Thus, Id3
-eT R have a unique molecular profile indicative of their development from Id3 + T R precursors, their elevated suppressive function and altered migratory capacity.
-T R are enriched and resident in non-lymphoid tissues In contrast to their elevated expression of inflammatory chemokine receptors, Id3 -eT R had the lowest expression of Ccr7 and S1pr1 which function together to promote T R recirculation through SLOs (21) (Fig 3H) . Additionally, expression of CD103 and CD69, which together act to retain tissue-resident memory T( RM ) cells in non-lymphoid sites, was strongly enriched in Id3 -eT R , suggesting these cells may be tissue-resident ( Fig 4A) (22, 23) . Indeed, utilizing published gene signatures of CD8 + T RM or circulating memory T cells (24), we found that the CD8 + T RM signature gene set was enriched in Id3 -eT R compared to either Id3 + cT R or Id3 + eT R , whereas the circulating memory gene set was enriched in the Id3 + T R populations ( Fig  4B) . Several groups have recently identified the ST2 (IL-33R)-Gata3 axis as a key determinant of T R residency and function in non-lymphoid tissues (8-10, 25, 26) . Accordingly, Id3
-eT R had the highest expression of all positively associated tissue T R genes such as Il1rl1 (ST2), Gata3, Areg, Irf4 and Rora, whereas Id3 + cT R had the lowest expression of these genes but high expression of negative regulators of tissue residence such as Tcf7, Klf2 and Lef1, and Id3 + eT R displayed intermediate expression for all of these genes (Fig 4C) . Consistent with their T RM -like transcriptional signature, Id3
-eT R were a minority of T R in LNs and spleen, but their frequency dramatically increased in nonlymphoid tissues, where they highly expressed the T RM surface markers CD103 and CD69 (Fig 4D-F) . Indeed, tissues such as the fat and skin contained almost exclusively Id3 -eT R . Of particular note Id3 -eT R were rarest in the lymph and blood, indicating that Id3 -eT R do not actively recirculate, but instead are retained as tissue-resident cells in nonlymphoid organs.
Despite significant interest in tissue-resident T R , the mechanisms regulating their differentiation and distribution are still poorly defined. Our data show that T R can be subdivided based on Id3 expression and known markers of cT R and eT R into distinct populations, and we propose a stepwise model in which T R downregulate Id3 as they progressively gain effector function, tissue homing capacity and residency in non-lymphoid organs. Similarly, Li et al. recently proposed a stepwise model for the differentiation of T R in adipose tissue in which activation in the spleen allowed T R to migrate into the adipose tissue, where IL-33 signaling drove their terminal differentiation and functional specialization (26) . High expression of costimulatory receptors such as ICOS and receptors for inflammatory cytokines would also allow Id3 -eT R to respond to inflammatory signals that enhance Foxp3-mediated transcriptional repression and promote eT R differentiation and function (27) , in part through activation of mTORC1 signaling (28) . Although the direct role of Id3 downregulation in the functional differentiation of T R is still not established, our data highlight the complexity of tissue T R development, and identify novel molecular pathways that are modulated during their stepwise differentiation.
Materials and Methods
Mice C57BL/6, RAG1-deficient and Foxp3-mRFP mice were purchased from The Jackson Laboratory. Id3-GFP mice were a generous gift from Ananda Goldrath (UCSD, La Jolla, California) and have been previously described (13, 15) . All mice were bred and housed under the approval of the Institutional Animal Care and Use Committee of the Benaroya Research Institute.
Cell Isolation Unless noted below, single cell suspensions isolated from tissues using manual disruption. PEC isolated by injecting sterile PBS into peritoneal cavity of euthanized mice, gentle disruption to dislodge cells and collection of injected PBS. IEL and LPL were isolated from pooled large and small intestine as previous described (29) . Lymphocytes were further purified by resuspension in 44% Percoll TM (GE Healthcare) layered over 67% Percoll TM and spun at 2,800rpm for 20 mins. Lung and fat were finely minced, digested with 0.26U/mL Liberase TM (Roche) and 10U/mL DNAse (Sigma) for 1 hr at 37°C and filtered. For skin tissue, ears were processed as above with 0.14U/mL Liberase TM and 10U/mL DNAse. For lymph collection, mice were fed 20mL/kg 'Half and Half' by oral gavage and sacrificed 2-3 hrs later. Lymph collected from the cisterna chyli was directly stained for flow cytometry. In vitro assays CD4 + T cells isolated from spleen and LN using CD4 microbeads (Miltenyi). 1x10 6 T cells cultured with platebound α -CD3 (2C11) and α -CD28 (37.51) from BioXcell at indicated concentrations for 48 hrs. In vitro T R suppression assays were performed as previous described (30) .
In vivo T R transfer
Sorted T R isolated from spleen and LN as described for RNA-seq. 100,000 sorted cells were injected retro-orbitally into RAG1-deficient hosts. Spleen, LN and blood of recipient mice collected two wks later and analyzed by flow cytometry.
Statistical Analysis
The p values were calculated by Prism software (GraphPad) using either an unpaired Student's t test or one way ANOVA as indicated. Values less than 0.05 were considered significant.
RNA-seq CD4
+ T cells were isolated using CD4 microbreads (Miltenyi) from either peripheral LNs or spleens of 3 littermate Id3-GFP x Foxp3-mRFP mice. Cells were sorted based on viability, CD4, CD44, CD62L, Id3-GFP and Foxp3-mRFP expression on a FACs Aria II (BD Biosciences). 500 cells were sorted directly into SMART-Seq v4 Ultra Low Input RNA Kit (Takara) lysis buffer and protocol followed to produce cDNA. Library construction was performed using a modified protocol of the NexteraXT DNA sample preparation kit (Illumina). Dual-index, single-read sequencing of pooled libraries was run on a HiSeq2500 sequencer (Illumina) with 58-base reads and an average depth of 8.6Mio reads per library. Base-calling and demultiplexing were performed automatically on BaseSpace (Illumina) to generate FASTQ files RNAseq analysis FASTQ files were processed to remove reads of zero length (fastq_trimmer v.1.0.0), remove adapter sequences (fastqmcf tool v.1.1.2) and perform quality trimming from both ends until a minimum base quality 
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